Danaher Posts Q2 Results, Joins Calix, Equifax And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session

S&P 500 Index Outlook: Top Three Catalysts for US Stocks This Week

This S&P 500 Index outlook explores the top catalysts for US stocks this week, including US consumer and producer inflation.

Consumer Tech (Aug 31-Sep 4): NVIDIA Buys World's Largest Open AI Developer, Trump Claims Total Control On Hormuz & More

President Donald Trump recently claimed the U.S. has “total control” over the Strait. NVIDIA acquire Hugging Face for $12.93 billion.

Earnings Volatility Watch: Oracle And Adobe Report, But the Wild Swings Belong to Smaller Names

Oracle and Adobe headline the week, both down about 20% in 2026, yet the biggest implied earnings moves belong to InnovAge, SailPoint and eight others.

Shares of software companies are trading lower after August's hotter-than-expected payrolls report increased expectations that the Federal Reserve could raise interest rates at its next meeting. A stronger U.S. dollar and higher rate expectations are weighing on growth stocks by reducing investor appetite for higher-risk assets.

JP Morgan Maintains Neutral on Agios Pharmaceuticals, Raises Price Target to $34

JP Morgan analyst Tessa Romero maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Neutral and raises the price target from $31 to $34.

Citigroup Maintains Buy on Agios Pharmaceuticals, Raises Price Target to $52

Citigroup analyst Samantha Semenkow maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Buy and raises the price target from $46 to $52.